Podcasts

Episode 24 | The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations

A/Prof Melissa Moore is joined by Dr Katharine See and Dr Naveed Alam to discuss and review the findings and implications for NSCLC patients.

The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations

Episode Summary

In this Podcast, we discuss early NSCLC management and treatment, particularly in light of how immunotherapy will impact surgical and respiratory medicine as the landscape evolves with new data. A/Prof Melissa Moore is joined by Dr Katharine See and Dr Naveed Alam to discuss and review the findings and implications for NSCLC patients.

Thank you to Roche for collaborating on this podcast.

Show Hosts

This episode’s host are:

A/Prof Melissa Moore, Educational Chair, TOGA; Medical Oncologist
Dr Katharine See, Director and Head of Respiratory Medicine, Northern Hospital, Melbourne
Dr Naveed Alam, Thoracic Surgeon, St Vincent’s Hospital and Epworth

Play Episode 24 | The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations

More Podcasts

51 – Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy

Podcasts
May 9, 2025

In this episode, Prof Tom John, Prof Georgina Long AO, and Prof Ken O'Byrne delve into technological advances spurred by COVID-19 vaccine development, promising results

50 – The Role of Liquid Biopsy in Modern Oncology

Podcasts
March 21, 2025

In this episode, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Steven Kao discuss the concept of liquid biopsy, its advantages and limitations, and its

49 – Exploring EGFR Exon 20 Insertion Mutations

Podcasts
March 7, 2025

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into

48 – A Conversation with Prof. Michael Boyer

Podcasts
February 6, 2025

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and

47 – Introducing Conversations in Lung Cancer Research

Podcasts
February 6, 2025

In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'

46 – Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy

Podcasts
December 13, 2024

Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC

Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

TOGA

Quicklinks

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.